Drivers of Clinical Trial Participation—Demographics, Disparities, and Eligibility Criteria

In the current issue of JAMA Oncology, Unger et al¹ provide an overview from SWOG in response to the recommendations to modernize eligibility criteria for clinical trials developed by the American Society of Oncology (ASCO), Friends of Cancer Research (Friends), and the National Cancer Institute (NCI) to support less restrictive eligibility criteria to broaden participation in clinical trials.^2-6